Sort
326,823 grants matching “clinical trial”
Nucleic acid vaccines targeting hantaviruses
$2,727,988Alexander Bukreyev · Vanderbilt University Medical Center · U19 · FY2024 · AI
High-Resolution, Spinal Cord Stimulation for Non-Opioid Treatment of Neuropathic Pain
$2,727,763Bryan L McLaughlin · Micro-Leads, Inc. · U44 · FY2020 · NS
WASHINGTON UNIVERSITY INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCES
$2,727,556Kenneth S Polonsky · Washington University · UL1 · FY2007 · RR
WASHINGTON UNIVERSITY INSTITUTE CTSA FOR CLINICAL TRIALS
$2,727,556Kenneth S Polonsky · Washington University · UL1 · FY2007 · RR
SWOG Biospecimen Bank
$2,727,061Nilsa Del Carmen Ramirez · Research Inst Nationwide Children'S Hosp · U24 · FY2018 · CA
Center for Cancer Research Clinical Trials Data Management Service
$2,726,880Caryn Steakley · Division Of Basic Sciences - Nci · ZID · FY2014 · CA
Pediatric Brain Tumor Consortium (PBTC)
$2,726,546Arzu Onar-Thomas · St. Jude Children'S Research Hospital · UM1 · FY2015 · CA
NONHUMAN PRIMATE CORE CELLULAR IMMUNOLOGY LABORATORY FOR AIDS
$2,726,389Sampa Santra · Beth Israel Deaconess Medical Center · N01 · FY2014 · AI
Helping to End Addiction Long-term (HEAL): Induced Pluripotent Stem Cell (iPSC)-Derived Cell Types for Pain, Addiction and Overdose
$2,726,004Ilyas Singec · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Medical Oncology Service Clinical Core
$2,725,789James L. Gulley · Division Of Basic Sciences - Nci · ZID · FY2014 · CA
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$2,725,447David S Stephens · Emory University · UL1 · FY2011 · RR
Discovery and validation of novel targets for pharmacotherapy of alcoholism
$2,725,388Markus Heilig · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2011 · AA
SUPPORT SERVICES FOR HIV AIDS CLINICAL TRIAL NETWORKS
$2,725,226Barbara Driver · Westat, Inc. · N01 · FY2023 · HD
Synaptic circuit mechanisms underlying psilocybin's therapeutic effects in the stressed brain
$2,725,051Yi Zuo · University Of California Santa Cruz · RF1 · FY2025 · MH
Cancer Research Consortium of West Michigan (CRCWM)
$2,724,475Kathleen J Yost · Corewell Health · UG1 · FY2025 · CA
Clinical Investigations On The Etiology And Therapy Of Neurogenetic Disorders
$2,724,142Henry F McFarland · Neurological Disorders And Stroke · Z01 · FY2007 · NS
SWOG Biospecimen Bank to Support NCI NCTN
$2,724,055Nilsa Del Carmen Ramirez · Research Inst Nationwide Children'S Hosp · U24 · FY2024 · CA
Alzheimer's Disease Research Center
$2,723,870Douglas R Galasko · University Of California, San Diego · P50 · FY2013 · AG
Hepatitis B Research Network - Data Coordination Center
$2,723,863Steven H. Belle · University Of Pittsburgh At Pittsburgh · U01 · FY2019 · DK
The role of senescent cells in dysregulating immune responses and pathogen control
$2,723,166Stephen C Jameson · University Of Minnesota · P01 · FY2024 · AI
Breast Cancer Family Registry Cohort
$2,723,075Esther M John · Cancer Prevention Instit Of California · UM1 · FY2012 · CA
Lentiviral Gene Therapy for Sickle Cell Disease And Immunodeficiency Disorders
$2,722,946Mitchell J Weiss · St. Jude Children'S Research Hospital · P01 · FY2022 · HL
MICHIGAN INSTITUTE CTSA FOR CLINICAL TRIALS
$2,722,841Daniel J Clauw · University Of Michigan At Ann Arbor · UL1 · FY2007 · RR
Integrating patient-specific clinical and biological factors towards individualizing utilization of proton and photon radiation therapy.
$2,722,827Theodore S Hong · Massachusetts General Hospital · P01 · FY2023 · CA
Phase I Trial of an Enterotoxigenic Escherichia coli (ETEC) Vaccine - VTEU
$2,722,822Carey Martin · University Of Maryland Baltimore · N01 · FY2015 · AI